15-Tritetracontene-27,43-dione,39-(acetyloxy)-1-[(4S,5E)-7-chloro-4-hydroxy-2-methylene-5,7-octadien-1-yl]-2,6,7,9,19,29,35-heptahydroxy-23-methoxy-4,10,28,30,35-pentamethyl-31-methylene-1,3,11,17,21,33,41-heptaoxy-,(1R,2R,3R,4S,5R,6S,7R,9S,10R,11R,15Z,17R,19S,21S,23S,25S,28S,29S,30R,33S,35S,37S,39S,41R)-,153745-94-9 Products Supply

Name: 15-Tritetracontene-27,43-dione,39-(acetyloxy)-1-[(4S,5E)-7-chloro-4-hydroxy-2-methylene-5,7-octadien-1-yl]-2,6,7,9,19,29,35-heptahydroxy-23-methoxy-4,10,28,30,35-pentamethyl-31-methylene-1,3,11,17,21,33,41-heptaoxy-,(1R,2R,3R,4S,5R,6S,7R,9S,10R,11R,15Z,17R,19S,21S,23S,25S,28S,29S,30R,33S,35S,37S,39S,41R)-
CAS NO.: 153745-94-9
Synonyms:
8,12,45,46,47,48,50-Heptaoxaheptacyclo[39.3.1.11,5.19,13.115,19.125,29.129,33]pentacont-23-ene-7,35-dione,3-(acetyloxy)-11-(7-chloro-4-hydroxy-2-methylene-5,7-octadienyl)-10,14,15,17,27,37,43-heptahydroxy-31-methoxy-18,36,38,43,49-pentamethyl-39-methylene-,[1S-[1R*,3R*,5S*,9S*,10S*,11S*(4R*,5E),13S*,14R*,15S*,17R*,18S*,19S*,23Z,25S*,27R*,29R*,31R*,33R*,36S*,37R*,38S*,41R*,43R*,49R*]]-;8,12,45,46,47,48,50-Heptaoxaheptacyclo[39.3.1.11,5.19,13.115,19.125,29.129,33]pentacont-23-ene-7,35-dione,3-(acetyloxy)-11-[(4S,5E)-7-chloro-4-hydroxy-2-methylene-5,7-octadienyl]-10,14,15,17,27,37,43-heptahydroxy-31-methoxy-18,36,38,43,49-pentamethyl-39-methylene-,(1S,3S,5R,9R,10R,11R,13R,14S,15R,17S,18R,19R,23Z,25R,27S,29S,31S,33S,36S,37S,38R,41S,43S,49S)-(9CI); Cinachyrolide A; Spongiostatin 4; Spongistatin 4
Molecular Structure:
Molecular Formula: C61H93 Cl O20

Send a message direct to supplier(s)*

Please post your buying leads,so that our qualified suppliers will soon contact you!

CAS NO.：
* Purchase Request：

* Your Email：
* Name：
* Gender：	Male Female
* Country/Area：
* Company Name：
* Tel：	- - Country - Code Area - Code Number

* Message：

Related products: 15-Tritetracontene-27,43-dione; 15-Tritetracontene-27,43-dione; 15-Tritetracontene-27,43-dione; 1/C51H74N2/c1-5-9-13-17-21-49(; 1/C28H41N5O15S.Na/c1-12(2)21(2; 8,12,45,46,47,48,50-Heptaoxahe; 8,12,45,46,47,48,50-Heptaoxahe; 1/C33H42O7/c1-19-25-17-24-18-2; 1/C27H27N3O3S/c1-30-25(20-11-1; 11',29'-di-tert-butyl-5',17',2; 8,28,41,42-Tetraoxatricyclo[35; 6-Oxa-13,26-dithia-3,10,17,20,; 1/C26H18O2/c1-17-16-23-21-9-5-; 8,28,41,42-Tetraoxatricyclo[35; 1/C22H28O6/c1-23-17-11-21(27-5; Propanoic acid,2-methoxy-,(1R,; Propanoic acid,2,3-dimethoxy-,; 10,32,45,46-Tetraoxatricyclo[3; 1/C30H52/c1-10-25(6)16-12-20-3; 2,4-Pyrrolidinedione,1-methyl-; 10,32,45,46-Tetraoxatricyclo[3; 10,32,45,46-Tetraoxatricyclo[3; 10,32,45,46-Tetraoxatricyclo[3; 1/C21H26N2O4/c1-3-14-8-9-19(25; 17-Oxa-1,4,7,23-tetraazabicycl; 5,7-Octadien-2-one,1-[(2R,3R,4; (2R,3R)-N-{(1'S,2S,7'R,9'Z,17'; Guanidine,[(4R,5R)-5-[(2S,4E,6; Formamide,N-[(1E,3R,4R,5R,9S,1; 22,33,34,35,36,37-Hexaoxahexac;